Spotlight
Clinical
Events
CME
Partners
Subscribe
- COVID-19
- Biosimilars
- Cataract Therapeutics
- DME
- Gene Therapy
- Workplace
- Ptosis
- Optic Relief
- Imaging
- Geographic Atrophy
- AMD
- Presbyopia
- Ocular Surface Disease
- Practice Management
- Pediatrics
- Surgery
- Therapeutics
- Optometry
- Retina
- Cataract
- Pharmacy
- IOL
- Dry Eye
- Understanding Antibiotic Resistance
- Refractive
- Cornea
- Glaucoma
- OCT
- Ocular Allergy
- Clinical Diagnosis
- Technology
Long-term use of glaucoma drugs poses risk for cornea, conjunctiva
Philadelphia-Corneal epithelial damage and conjunctival inflammation, risks of long-term use of glaucoma medications, may be minimized by paying close attention to the preservative concentration as well as thepH of the medications, according to Robert J. Noecker, MD, MBA.
Related Videos
Related Content
